上海复星医药(集团)股份有限公司
Shanghai Fosun Pharmaceutical Group Co LtdCNCNYShanghai Fosun Pharmaceutical Group Co Ltd (HK:2196) — Drug Manufacturers - Specialty & Generic. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte Kohta
- Veebileht
- fosunpharma.com
- Sektor
- Healthcare · Drug Manufacturers - Specialty & Generic
- Peakontor
- Shanghai, China
- Tegevjuht
- Yi Liu
- Töötajad
- 40 684
- Asutatud
- 1994
- Börsil Alates
- 30.10.2012 (HK:2196)
- Ringluses Olevad Aktsiad
- Vabalt Kaubeldavad Aktsiad
- 1.63 mld
- Turukapitalisatsioon
- 9.27 mld HKD
- Siseringi Isikud
- 43.02%
- Institutsionaalsed Investorid
- 8.48%
- ISIN
- CNE100001M79
- Väljamaksesuhe
- 54.2%
- FCF
- 885 mln CNY
- Väljamakse / FCF
- 213%
- Võlg
- 39.5 mld CNY18 a FCF
- Dividendistaaž
- 25 a
- Kasum, FCF ja dividendid makstud — 12 kuu jooksul kuni 31.03.2026 (ettevõtte viimane raport).
Kirjeldus
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Dividendid
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) maksab dividende kord aastas. Aastas (12 kuud kuni viimase teatatud maksega): 0.45 HKD aktsia kohta (maksed: 1). See on umbes 2.60% praegusest aktsiahinnast. Makseajaloo põhjal oodatakse järgmist ex-dividendi kuupäeva umbes 14.07.2027. Katkematu dividendiajalugu: 25 aastat.
| Ex-Kuupäev | Väljamakse | Summa | % | Tüüp | Tikker |
|---|---|---|---|---|---|
| 2026-07-16 | — | 0.4500 HKD | 2.6/2.6 % | aastane | HK:2196 |
| 2025-07-24 | — | 0.3500 HKD | 1.9/1.9 % | aastane | HK:2196 |
| 2024-07-26 | — | 0.3000 HKD | 2.3/2.3 % | aastane | HK:2196 |
| 2023-07-31 | — | 0.4600 HKD | 2.2/2.2 % | aastane | HK:2196 |
| 2022-06-08 | — | 0.6600 HKD | 2.0/2.0 % | aastane | HK:2196 |
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| Wu (Yi Fang) (Director) | ≈0.04% | 1.06 mln | 2018-12-31 |
Logi Sisse Google